Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guolin Zhang

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Journal of Electrocardiology|November 15, 2017
Whole exome sequencing identified a pathogenic mutation in RYR2 in a Chinese family with unexplained sudden deathYubi Lin, Siqi He, Zili Liao, et al.
Journal of Medicinal Chemistry|June 13, 2022
Discovery of a Novel Small-Molecule Inhibitor Disrupting TRBP-Dicer Interaction against Hepatocellular Carcinoma via the Modulation of microRNA BiogenesisTing Peng, Yujiao He, Tao Wang, et al.
Journal of Medicinal Chemistry|December 21, 2021
Identification of Pyruvate Carboxylase as the Cellular Target of Natural Bibenzyls with Potent Anticancer Activity against Hepatocellular Carcinoma via Metabolic ReprogrammingYuwen Sheng, Yuwen Chen, Zhongqiu Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancerTakeshi Yoshida, Guolin Zhang, Matthew A Smith, et al.
Nature Communications|April 4, 2024
VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 responseThomas Thisted, F Donelson Smith, Arnab Mukherjee, et al.
Molecular Systems Biology|November 6, 2013
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanismsJiannong Li, Keiryn Bennett, Alexey Stukalov, et al.
Molecular Cancer Research : MCR|January 13, 2022
Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell MigrationAnurima Majumder, Sina Hosseinian, Mia Stroud, et al.
Proteomics. Clinical Applications|June 10, 2011
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancerElizabeth R Remily-Wood, Richard Z Liu, Yun Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMMLChristopher T Letson, Maria E Balasis, Hannah Newman, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2020
Managing a Large-Scale Multiomics Project: A Team Science Case Study in ProteogenomicsPaul A Stewart, Eric A Welsh, Bin Fang, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Journal of Electrocardiology|November 15, 2017
Whole exome sequencing identified a pathogenic mutation in RYR2 in a Chinese family with unexplained sudden deathYubi Lin, Siqi He, Zili Liao, et al.
Journal of Medicinal Chemistry|June 13, 2022
Discovery of a Novel Small-Molecule Inhibitor Disrupting TRBP-Dicer Interaction against Hepatocellular Carcinoma via the Modulation of microRNA BiogenesisTing Peng, Yujiao He, Tao Wang, et al.
Journal of Medicinal Chemistry|December 21, 2021
Identification of Pyruvate Carboxylase as the Cellular Target of Natural Bibenzyls with Potent Anticancer Activity against Hepatocellular Carcinoma via Metabolic ReprogrammingYuwen Sheng, Yuwen Chen, Zhongqiu Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancerTakeshi Yoshida, Guolin Zhang, Matthew A Smith, et al.
Nature Communications|April 4, 2024
VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 responseThomas Thisted, F Donelson Smith, Arnab Mukherjee, et al.
Molecular Systems Biology|November 6, 2013
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanismsJiannong Li, Keiryn Bennett, Alexey Stukalov, et al.
Molecular Cancer Research : MCR|January 13, 2022
Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell MigrationAnurima Majumder, Sina Hosseinian, Mia Stroud, et al.
Proteomics. Clinical Applications|June 10, 2011
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancerElizabeth R Remily-Wood, Richard Z Liu, Yun Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMMLChristopher T Letson, Maria E Balasis, Hannah Newman, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2020
Managing a Large-Scale Multiomics Project: A Team Science Case Study in ProteogenomicsPaul A Stewart, Eric A Welsh, Bin Fang, et al.
Pageof 24